Fundraising Fox

Veronica Gambillara Fonck

Investor

Partner at Pureos Bioventures

Zurich, Switzerland

Writes $100K – $5M checks · typically $1.5M

About

Veronica Gambillara Fonck is a partner at Pureos Bioventures and serves as Chairperson of the Board at Minervax ApS. She brings experience in corporate and product development strategy, clinical and regulatory matters in biotech and medtech, and international operations across multiple language markets.

Experience

  1. Minervax ApSChairperson of the Boardcurrent2024 — presentCopenhagen, Capital Region of Denmark, Denmark
  2. Pureos BioventuresPartnercurrent2022 — presentZurich, Switzerland
  3. GlycoEra AGCEO-and Co-Founder2021 — 2022Zurich, Switzerland
  4. LimmaTech Biologics AGCEO-Co-founder2015 — 2021Schlieren, Kanton Zürich, Switzerland
  5. Glycovaxyn AGExecutive Director, Clinical and Regulatory Affairs2012 — 2015Zurich
  6. Glycovaxyn AGDirector Business Development2011 — 2012Zurich
  7. Glycovaxyn AGDirector Clinical and Regulatory Affairs2009 — 2011
  8. AllerganManager Clinical Affairs2007 — 2009
  9. EndoArt SAProject Manager2006 — 2007
  10. Ecole Polytechnique de LausanneResearch Assistant2001 — 2005

Education

  1. IMDHigh Performance Boards Program2019
  2. IMDMaster of Business Administration - MBA, Finance2017
  3. The MBA training Company3 days MBA in Pharmaceuticals2010
  4. Advanced Course of VaccinologyCME credits, Vaccine2010
  5. The George Washington University School of BusinessManaging Projects2009
  6. EPFLPhD, Biomedical Engineer2000 — 2005
  7. Management BioTech, BioMed and Pharma VenturesCertificate of Advanced Studies, Management BioTech2003 — 2004
  8. ETH ZürichEngineer, Material Engineer1995 — 2000

Skills & more

Business Development10Clinical Affairs7Regulatory Affairs12Regulatory Submissions10Clinical Trials19Clinical Development16Clinical Research11Vaccines7Immunology6Biochemistry3Biomedical Engineering3Molecular Biology4
+12 moreLifesciencesMedical DevicesPharmaceutical IndustryProject ManagementBiotechnologyBusiness StrategyInfectious DiseasesR&DLife SciencesManagementLeadershipStrategy

Languages English · French · German · Italian

From Veronica's professional profile.

Same school

Also attended IMD143

+ 137 more

Also attended The George Washington University School of Business35

+ 29 more

Also attended EPFL61

+ 55 more

Also attended ETH Zürich136

+ 130 more

Shared employers

Colleagues at Pureos Bioventures